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Abstract
Many techniques for the study of complex populations provide either specific information on a small number of variants or
general information on the entire population. Here we describe a powerful new technique for elucidating mutation
frequencies at each genomic position in a complex population. This single base extension (SBE) based microarray platform
was designed and optimized using poliovirus as the target genotype, but can be easily adapted to assay populations
derived from any organism. The sensitivity of the method was demonstrated by accurate and consistent readouts from a
controlled population of mutant genotypes. We subsequently deployed the technique to investigate the effects of the
nucleotide analog ribavirin on a typical poliovirus population through two rounds of passage. Our results show that this
economical platform can be used to investigate dynamic changes occurring at frequencies below 1% within a complex
nucleic acid population. Given that many key aspects of the study and treatment of disease are intimately linked to
population-level genomic diversity, our SBE-based technique provides a scalable and cost-effective complement to both
traditional and next generation sequencing methodologies.
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Introduction
The identification of specific genetic changes responsible for
molecular, cellular, and organismal phenotypes is central to many
biological questions. In classical genetic analyses, a phenotype is
linked to either the responsible gene or a segregating polymor-
phism. The power of this approach has recently increased with the
development of high-density single nucleotide polymorphism maps
in several organisms [1–3]. In contrast, many questions require
quantification of allele frequency or genetic diversity at the
population level. For example, genetic association studies of
complex traits often rely on measurements of several indepen-
dently segregating single nucleotide polymorphisms in diverse
populations [4]. In infectious diseases, a single host may harbor a
complex mixture of microbes that evolve new traits over short
periods of time (e.g. drug resistance or shifts in tropism, see [5]). At
the molecular level, genetic rearrangements and somatic hyper-
mutation lead to extensive diversity within B and T cell
populations [6–8].
A major limitation to such studies is the lack of efficient and
economical methods for comprehensive and quantitative charac-
terization of the full range of genotypes in a population.
Techniques such as allele specific polymerase chain reaction
(PCR), Sanger sequencing, and restriction fragment length
polymorphism analysis provide very specific information on a
small subset of genotypes. In contrast, single stranded conforma-
tional polymorphism (SSCP)[9], heteroduplex mobility
(HMA)[10], and MALDI-TOF based assays [11] provide more
general information on the entire population. The revolution in
ultra high throughput sequencing (UHTS) technology may bridge
this gap, but the utility of the current platforms is limited by the
relatively high error rate and considerable start up and operating
cost [12].
Several groups have successfully used microarrays to measure
the frequency of known single nucleotide polymorphisms (SNP) in
complex populations. In many platforms, SNPs are identified by
differential hybridization of nucleic acid to high-density micro-
arrays tiled with candidate sequences [13,14]. These techniques
often suffer from a high false positive rate and are less accurate
than the recently developed arrayed primer extension approach
[15]. In array-based primer extension, a sample nucleic acid is
hybridized to arrayed oligonucleotides targeting previously
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of the oligonucleotides using the hybridized sample as template.
Depending on the identity of the base at a given SNP, a different
dye (or hapten) -conjugated chain-terminating dideoxynucleotide
is added to the 39-end the oligonucleotide. In the absence of copy
number variation, SNP detection is straightforward, since most
alleles are homozygous or heterozygous at any given position with
respect to a single individual. While this massively parallel
technique allows for simultaneous detection of hundreds to
hundreds of thousands of SNPs [16,17], it requires a priori
knowledge of the relevant polymorphisms. Many questions in
population genetics, however, require a broader, less directed
approach to genetic diversity. For example, determining the
collective nucleotide sequence of a highly variable population of
viruses or T cell receptors can be compared to SNP analysis, with
the possibility of a SNP at essentially every position.
Here we describe the development of a platform that utilizes an
enhanced version of arrayed primer extension for the measure-
ment of genotype frequencies within a complex population.
Because our method relies on single base extension with labeled
dideoxynucleotides on replicate arrays, we are able to measure
nucleotide frequency without prior knowledge of candidate SNPs.
Extensive optimization of this platform allows unbiased detection
of single base changes present at 0.3–1% frequency. We
demonstrate the performance of our novel mutation distribution
analysis of populations (MDAP) microarray by characterizing the
mutant spectrum of a poliovirus population subjected to a
mutagenic drug. Because our system is based on the ubiquitous
and economical spotted microarray platform, it is readily adapted
to many biological questions and within the reach of a typical
university-based laboratory.
Results
Overview of the mutation distribution analysis of
populations (MDAP) microarray platform
We developed a single base extension microarray platform with
the goal of determining individual nucleotide frequencies at each
genomic position within a complex viral population. For our pilot
studies, we focused on the region of the poliovirus genome that
codes for the structural proteins. We designed overlapping,
antisense 70-mer oligonucleotides that hybridize and terminate
at each of the 2,643 positions in the capsid portion of the
polyprotein open reading frame (Figure 1A). These oligonucleo-
tides were spotted onto epoxy-coated glass slides in triplicate and
subsequently covalently coupled to the slide surface (Figure 1B).
We generated single-stranded, positive-strand DNA fragments
from poliovirus RNA. Each sample was divided evenly and
hybridized to four arrays under identical conditions. We then
performed polymerase-based extension on the hybridized frag-
ments using single chain-terminating dideoxynucleotides (ddNTPs,
Figure 1C). These ddNTPs were cyanine (Cy)-labeled, and each of
the four arrays was exposed to a different mix of one part Cy5
labeled target dideoxynucleotides, one part Cy3 labeled target
dideoxynucleotides and two parts each of a mix of the remaining
three background ddNTPs. After extension, we removed the
poliovirus DNA by boiling in sodium dodecyl sulphate, leaving
only covalently bound oligonucleotides, now terminating with
labeled ddNTPs (Figure 1D).
We measured nucleotide frequencies at each position of the
capsid region by comparing the Cy5 and Cy3 intensities across a
set of four arrays. For example, an ‘A’ array received a mixture of
one part Cy5 labeled ddATP, one part Cy3 labeled ddATP, and
two parts each Cy3 labeled ddCTP, ddGTP, and ddUTP. The
‘‘C’’, ‘‘T’’, and ‘‘G’’ three arrays received a corresponding mixture
of 3 background nucleotides plus a different ‘target’ nucleotide
split evenly between Cy3 (G, green) and Cy5 (R, red) labels. We
corrected for differential incorporation rates and fluorescence
intensities using a set of oligonucleotides expected to extend Cy3
and Cy5 labeled ddNTPs with equal frequency. The global dye-
specific intensities were normalized such that the median values
for each were equal on these control oligonucleotides. After
normalization Rn accounts for 50% of the total florescence derived
from the incorporation of nucleotide n, and Gn + Rn represents the
total florescence observed from extension of all four nucleotides. It
follows that equation (1) below closely approximates the fraction of
oligonucleotides F within a given spot that were extended by the
target nucleotide n.
Fn~ 2Rn = Rnz Gn ðÞ ð 1Þ
Since equation (1) represents the fraction of oligonucleotides
within a spot that were extended with the labeled nucleotide of
interest on that array, the sum of this ratio across all four arrays
was normalized to one to eliminate any global dye bias.
Nn~Fn=
X
xƒ A,C,G,T
Fn ð2Þ
Three identical spots assaying each position p within the
genome were used to calculate the median value of Nn. This value
was used as the final frequency of nucleotide n in the population at
position p,N n,p.
Nn,p~ median Nn for all spotsassaying position p ð3Þ
Optimization of MDAP array to a detection threshold
below 1%
During the process of design, implementation, and optimization
of the MDAP array, we identified many sources of experimental
noise that were either minimized or eliminated altogether. The
signal to noise ratio of the array served as a measure of array
quality and was the major target for optimization. Because any
natural poliovirus population is heterogeneous, we used in vitro
transcribed RNA derived from a plasmid poliovirus clone as a
reference set [18,19]. While T7 RNA polymerase does have an
error rate of approximately 10
25, any mutants generated during in
vitro transcription would be present at a frequency of ,0.001%
and below the limit of detection for our assay [20,21]. In our
analyses, any signal corresponding to incorrect bases was therefore
considered to be the background noise of the assay. In order to
achieve the final design goal of sensitivity below 1%, four major
components of the experiment were optimized: surface chemistry,
oligonucleotide properties, hybridization, and extension.
Although we found that slide chemistry did not directly affect
the signal to noise ratio, few slide chemistries could survive the
required extension and stringent wash steps of the assay. For
example, poly-l-lysine coated slides deteriorated during the
polymerase-based extension step. Others were unable to withstand
the final wash in boiling sodium dodecyl sulphate, which removed
all nucleic acid not covalently linked to the slide surface. Of the
slide chemistries tested (poly-l-lysine, epoxy, aldehyde, and amino-
silane), epoxy slides exhibited the best combination of spot
Single Base Extension by Array
PLoS ONE | www.plosone.org 2 October 2009 | Volume 4 | Issue 10 | e7453Figure 1. Overview of microarray design and experimental protocol. (A) Schematic of the poliovirus genome. Antisense 70-mer
oligonucleotides were designed and synthesized against the capsid region (VP1-4) of the single open reading frame. (B) Four identical microarrays
were printed onto two epoxy-coated glass slides, which allowed the oligonucleotides to be covalently coupled to the slide surface. (C) Single
stranded DNA was hybridized to all four arrays for a given sample, and enzymatic single base extension (SBE) was performed on each array in the
presence of a different fluorescently-conjugated chain terminating dideoxynucleotide. (D) The original sample was removed by high stringency wash,
leaving only the oligonucleotides, which either remain unextended or have been extended by a single dye-labeled nucleotide. (E) The arrays were
scanned to determine the dye-specific fluorescence intensities for each spot. (F) The base-specific signal from each spot (y-axis) is plotted against a
normalization signal (x-axis in F) generated by SBE in the presence of all four ddNTPs. The ratio of base-specific extension over total extension is
computed for the analogous feature on all four arrays. (G) Base specific signal as a function of genome position. Background bars represent the
expected nucleotide, based on the wild-type poliovirus genome. Four foreground bars show the observed frequencies of A(red), C(green), G(blue),
and T(yellow) at each position. In this homogeneous population, the ‘‘mutant’’ or incorrect calls reflect the noise of the platform.
doi:10.1371/journal.pone.0007453.g001
Single Base Extension by Array
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including 3xSSC, Formamide, Betaine, nextSpot, phosphate,
Tween20 and sarcosyl, with 3xSSC providing the best combina-
tion of performance and utility.
We empirically determined the optimal oligonucleotide length.
Oligonucleotides assaying the same genomic position were
synthesized at lengths of 20 to 70 nucleotides in ten nucleotide
increments. We designed three sets to interrogate different
positions, and printed them in quadruplicate on the array.
Hybridization and extension were performed with a homogeneous
poliovirus population and the raw intensity of the extension signal
recorded for all 72 observations (3 positions x 6 oligonucleotides of
varying length x 4 spots for each oligonucleotide). We detected
little variation in median signal intensity among 50-, 60-, and 70-
mers but observed a greater than 50% reduction in signal with
oligonucleotides shorter than 50 mers (Figure S1). These data are
in accordance with previously published reports on the relation-
ship between hybridization performance and oligonucleotide
length [22,23]. We therefore used 70-mer oligonucleotides in all
subsequent experiments.
We found it necessary to minimize two other sources of
oligonucleotide noise. For two to three percent of the oligonucle-
otides, self-hybridization or dimerization provided a valid template
for extension. This resulted in very strong base-specific noise. To
eliminate this technical artifact, we identified oligonucleotides
prone to self-hybridization using an Mfold-based algorithm.
Mutations were then introduced into array oligonucleotides that
would preserve appropriate hybridization but prevent self-
extension ([24],Figure S2). This technique proved successful,
reducing the noise on these oligonucleotides to background levels.
We also identified an unexpected source of noise related to the
oligonucleotide manufacturing process. Based on observed
oligonucleotide-specific patterns of noise, we inferred that greater
than one percent of oligonucleotides within each spot were missing
one or more bases at their 39 termini. This resulted in aberrant
extension in place of the absent nucleotide at a frequency of one to
three percent (Figure S3). Since these oligonucleotides were
synthesized from 39 to 59, the missing nucleotides were a result of
failures in the initial stages of synthesis. We therefore tested
oligonucleotides synthesized by an alternate process (base-specific
rather than universal support, see Materials and Methods) and
observed a 29% reduction in mean noise levels across the array
(Figure S4).
We next optimized the hybridization and extension steps. Both
single-stranded and double-stranded nucleic acid have been used
successfully in microarray experiments. We found that single-
stranded nucleic acid exhibited both increased raw extension
intensities and decreased noise ratios compared to double-stranded
template (Figure S5). The difference is striking, with an
approximately 30-fold increase in signal and no significant change
in the corresponding noise levels. Hybridization time also had a
significant impact on global oligonucleotide noise. By reducing the
hybridization time from 12 hours to 30 minutes, we decreased the
absolute median noise level from 1.8% to 0.4% of the signal, a
relative reduction of 78% (Figure S6). Although decreasing the
duration of the extension reaction from one hour to five minutes
did not produce a similar improvement (Figure S7), these two
protocol changes did decrease the per sample assay time by 80%.
By optimizing the parameters above, we were able to correctly
determine the correct base at each position across the viral capsid
with a median signal to noise ratio of 250:1 for a homogeneous
population (Figure S8). In a typical experiment, 70% of
oligonucleotides had a signal to noise ratio greater than 100:1,
corresponding to a sensitivity of 99%. Many other experimental
parameters were tested throughout the optimization process
(Table S1), with little or no effect on array performance. One
important source of noise is experiment-specific and dependent on
the relative frequencies of mutations in the population. If a single
mutation rises to high levels within a population, it can affect the
performance of oligonucleotides assaying nearby positions.
Template molecules containing the mutation will hybridize
correctly, but mismatches between the template and the 39 end
of an oligonucleotide decrease the efficiency of the single base
extension (Figure S9). Control experiments in which 100% of the
population contained a specific mutation showed that extension
was nearly abolished when mismatches occurred at the neighbor-
ing position. We observed smaller effects for mismatches up to six
nucleotides (approximately one half-turn of the primer-template
duplex) from the 39 end of the oligonucleotide (data not shown).
This effect can be abrogated by designing contingency oligonu-
cleotides for a given position that include nearby polymorphisms
known to be present in the sampled population.
MDAP can accurately measure mutation frequency in a
controlled population
We tested the sensitivity and accuracy of the MDAP platform
by measuring the frequency of specific mutants within a defined
population. We introduced a set of point mutations into the
capsid region of the poliovirus genome and generated the
corresponding in vitro transcribed RNA. These mutated genomes
were combined with each other and unmodified poliovirus RNA
such that each mutant RNA would be present at a frequency of
10%. We then diluted this pool serially with unmodified RNA, to
obtain mutant frequencies of 3.16%, 1.0%, and 0.316%. Single-
stranded DNA was prepared from each of the four dilutions. As
controls, we used DNA prepared from two samples of unmodified
poliovirus RNA. We then processed these samples using the MDAP
array. Mutation frequencies measured from the array are shown
in Figure 2. The accuracy varied across the sample set, with a
mean observed frequency in the 10% mixture of 8.06% and a
standard deviation of 3.6%. Predicted frequencies of the
mutations in diluted samples were very consistent, with R squared
values of linear fits to each dilution series ranging from 0.991 to
0.999.
The sensitivity of the array was measured by comparing each of
the mutant-templated arrays to those templated by unmodified,
wild type nucleic acid. The distribution of mutation frequencies
observed for a given spot in the control arrays was assumed to be
noise for all non-wild type nucleotides. This background signal was
used as a baseline from which to calculate a standard z-score for
each observation on the experimental arrays. The minimum z-
score across three spot replicates on each of two array replicates
for each sample was taken as the significance score for a given
nucleotide and position. Introduced mutations were considered to
be detectable if their z-score was higher than all of the significance
scores for unexpected mutations (false positives) on the control
samples. Data points to the left of the dotted line in Figure 2
denote introduced mutations whose significance score fell below
those of the most significant false positives in the sample. At a
frequency of 0.3%, only one of the introduced mutations
(A3278G) was detectable. When the introduced mutations were
mixed at 1%, five of the six had z-scores greater than any
unexpected mutation. These data suggest that the average limit of
detection for the MDAP array is between 0.3% and 1%. The
observed variability in position-specific sensitivity is an inherent
feature of hybridization-based methodologies and reflects the
nonrandom influence of natural sequence variation.
Single Base Extension by Array
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To determine the ability of the array to monitor genome-wide
changes in a complex population over time we investigated the
effects of the nucleoside analog ribavirin on a poliovirus
population. We and others have previously shown that ribavirin
is an RNA virus mutagen [25]. We generated a wild type poliovirus
population by transfecting in vitro transcribed RNA into HeLa S3
cells. Viral supernatants were harvested from transfected cells
and passaged once at high multiplicity of infection (MOI) to
generate a population that served as the passage 0 (P0) viral stock
for the experiment. We used this stock to infect four cell
preparations exposed to varying concentrations of ribavirin
(0 mM, 100 mM, 400 mM, and 1000 mM). Passage 1 (P1) virus
was harvested from each sample upon cytopathic effect and used
to infect a fresh monolayer of cells at the same drug
concentration. The virus resulting from this second round of
infection was termed P2. We analyzed this set of samples to
identify the mutations present in the population as a function of
drug concentration and time.
Because all poliovirus populations are heterogeneous [18,19], we
used virus passaged in the absence of drug as a reference. This
control allowed us to distinguish mutations induced by ribavirin
from standing genetic variation. Based on data derived from two
array replicates of this sample, we calculated a significance score
(standard z-score) to estimate the relative likelihood that a given
observation from other passages or drug concentrations fell outside
the standard variation of the base-specific signal for a viral
population. Using this method, small changes in array signal were
assigned z-scores to represent our confidence that the observed
change in signal reflected actual changes in mutation frequency as
opposed to oligonucleotide noise or ‘‘background’’ viral genetic
diversity. A high z-score would suggest that a given mutation was
overrepresented in the population and correlated with drug
treatment or passage. To quantify global changes in mutation
frequency, we plotted the mean z-score for each of the twelve
possible nucleotide changes as a function of time and drug
concentration (e.g. A to C, A to G, A to T, C to A, C to G, C to T,
etc.). A clear overrepresentation of cytosine and thymine (C to T)
and guanine to adenine (G to A) mutations was apparent in viral
populations passaged in ribavirin, and their frequency increased
with drug concentration (Figure 3). We observed little change in
the frequency of other mutation classes across the entire capsid
sequence. These data are consistent with ribavirin’s known mode
of action and demonstrate the ability of the MDAP technique to
identify and characterize the spectrum of mutations in a complex
population [25,26].
Quasispecies theory predicts that RNA viral populations are
robust to the effect of mutation, and that many of the mutations
in viable viruses do not code for amino acid changes [27].
According to this model, the virus would evolve over a neutral
fitness landscape and many of the mutations would be
synonymous in nature. We therefore estimated the ratio of
nonsynonymous to synonymous changes within our mutagenized
population as measured by MDAP. By assuming that the vast
majority of observed mutations were single nucleotide changes
within a codon, each mutation was assigned to the NS
(nonsynonymous) or S (synonymous) class of mutations, and the
average z-score of each class was computed for every codon. In
P1, the average z-score of S mutations was not significantly
different than that of NS mutations (p,0.068, 0.13, 0.28 for 100,
400, 1000 mM ribavirin, respectively),s u g g e s t i n gt h a tt h e r ew a s
no bias for noncoding changes at early passages. In P2, however,
t h ea v e r a g ez - s c o r eo fSm u t a t i o n s was significantly higher than
t h ea v e r a g es c o r eo fN Sm u t a t i o n s( p ,0.08, 0.006, 0.07). These
data indicate that synonymous changes accumulate over time,
consistent with negative selection against coding changes. To
determine whether there were ‘hot spots’ of selective pressure, we
calculated a per codon estimate of the selective pressure as the
d i f f e r e n c eb e t w e e nt h ea v e r a g ez - s c o r eo fn o n s y n o n y m o u s
mutations and the average z-score of synonymous mutations
within the codon. Ann excess of nonsynonymous mutations
w o u l dg i v eap o s i t i v ev a l u ea n ds u g g e s tp o s i t i v es e l e c t i o na tt h a t
position. Using this metric, we found no evidence for nonsynon-
ymous ‘‘hotspots’’ across the capsid region of the genome (Figure
S10). The observed variability in the z-scores for different SNPs
likely reflects the fact that certain sites are subject to reduced
selective pressure under our experimental conditions. Mapping
Figure 2. Array accuracy and sensitivity. The mutation frequencies
measured by MDAP (y-axis) are plotted against the actual (expected)
mutation frequency (x-axis). Genomes were mutated at single positions
and mixed together at frequencies of 0.3%, 1%, 3%, and 10%, with the
remainder of the population in each case derived from an unmutated
sample. Two array replicates were performed to generate error bars
representing the standard deviation of six total observations (three
oligonucleotide replicates on each of two array replicates). Titles
indicate wild type base, genome position, and mutated base. The
vertical dotted line in each panel indicates the significance cut-off
based on z-scores derived from a homogeneous control sample. Data
points to the left of the dotted line are not statistically significant.
doi:10.1371/journal.pone.0007453.g002
Single Base Extension by Array
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not, however, suggest any higher order, biological correlations.
Together these data indicate that the majority of the viable
mutants are selectively neutral and that ribavirin acts in a
random fashion across the genome.
To better characterize the nature of selection in drug-treated
viral populations, we performed cluster analysis of the changes
observed in the ribavirin samples. Mutations were clustered
according to their relative z-scores in passages one and two
(Figure 4). We identified a number of strong, monotonically
increasing mutations that formed a particularly distinct cluster
(Figure 4C). Consistent with our global analysis of mutation
frequency, nearly all of these mutations were G-to-A or C-to-T
changes. To determine whether these mutations were increasing
from passage to passage due to low levels of fixation in the
population, we computed the frequency of synonymous and
nonsynonymous changes within the cluster. While 20% of all
possible mutations in the region analyzed by this array are
synonymous changes, 74.3% of the 214 mutations in this cluster
were synonymous. (p,0.01). Therefore, the vast majority of
mutations that accumulate in the population over time do not code
for amino acid changes and are less likely to alter viral fitness. Our
cluster analysis also indicates that there is strong negative selection
against coding changes, which is consistent with our prior work on
lethal mutagenesis of RNA viruses [28].
Observing the Dynamics of Ribavirin Resistance
While drug resistant variants are known to exist in viral
populations prior to drug exposure, conventional sequencing-based
assays are only able to detect mutants present at a high frequency.
The sensitivity and low detection threshold of the MDAP platform
offer an opportunity to observe the dynamics of drug resistance at a
relatively early stage. We and others have identified a point
mutation within the poliovirus 3D polymerase gene that mediates
ribavirin resistance [29,30]. This mutation in the RNA-dependent
RNA polymerase (glycine to serine at amino acid 64) results in
increased polymerase fidelity, and is thought to decrease the rate at
which the polymerase incorporates ribavirin when replicating the
poliovirusgenome. To quantify the levelsof this drug resistant mutant
in the populations described above, an additional oligonucleotide
was designed to assay position 6176 of the poliovirus genome
(Figure 1A). The measured prevalence of this mutation is shown in
Figure 5. In the presence of 100 mM ribavirin, the frequency of the
G64S mutation increases slowly, reaching 0.24% of the population
after two passages. In contrast, by passage two in 400 mM ribavirin,
the G64S mutation is present in 7% of viral genomes. Not
surprisingly, the G64S mutation increases in frequency even more
quickly in the presence of 1000 mM ribavirin, reaching 28% of the
population after just two passages. These results highlight the
complex nature of drug resistance and the ability of the MDAP
platform to identify minority variants within a viral population.
Figure 3. Global monitoring of mutations in a viral population. A wild type population was generated by transfection of in vitro transcribed
genomic RNA into HeLa S3 cells. This supernatant was passed once on a fresh monolayer to derive a P0 stock. This population was serially passaged
at MOI 0.1 in the presence of 0 mM, 100 mM, 400 mM or 1000 mM of the antiviral nucleoside analog ribavirin. The significance (standard z-score) of
base changes as compared to the reference (eight replicate observations of the P1 0 mM ribavirin sample) was recorded and the mean significance
scores were plotted for every observed mutation type. A mean z score greater than zero indicates increasing average significance of the given
mutation type. Values less than zero indicate that the observed frequencies are below the assay background. Specific classes of mutations are shown
at the bottom of the figure. The two types of mutations showing the most significant change throughout the experiment are colored blue (C-to-T)
and green (G-to-A).
doi:10.1371/journal.pone.0007453.g003
Single Base Extension by Array
PLoS ONE | www.plosone.org 6 October 2009 | Volume 4 | Issue 10 | e7453Figure 4. Mutations with Similar Behavior Reveal Selective Pressure. Z-scores representing the significance of mutational changes away
from P1 in the absence of drug were clustered, and clusters showing interesting behavior were further analyzed for selective pressure and mutation
type. Each row in the cluster represents a single mutation, and each column represents a single passage. Green bars denote mutations that are
decreased in frequency compared to P1 no drug, black indicates no significant change, and red bars indicate mutations that have increased in
frequency. Pie charts show the composition of nucleotide changes and synonymous or nonsynonymous nucleotide changes in the indicated clusters
A–C.
doi:10.1371/journal.pone.0007453.g004
Single Base Extension by Array
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In addition to the MDAP array described here, we have also
developed freely available companion software to facilitate rapid
and detailed analysis of array results. The open source MDAP
software package provides an intuitive graphical user interface,
allowing users to load GPR (GenePix Results) files from multiple
arrays and generate sample files containing all data relevant to a
single sample. Data can be explored through a series of
automatically generated graphs, allowing the user to quickly
examine data by genome position, fluorescence intensity, and
mutation frequency at the level of a single array, sample, or even a
reference set of samples. Mutation frequencies, as well as z-scores
when a reference set is available, can be exported to text files for
further analysis in other programs. The MDAP software package
is implemented in python, and can be used on all major
computing platforms. The source code is available at http://
derisilab.ucsf.edu/software/MDAP/.
Discussion
Many techniques for the study of complex populations provide
either specific information on a small number of variants or
general information on the entire population. To address this
shortcoming, we have developed an economical and scalable
method that provides comprehensive and unbiased information on
allele frequency across an entire genome. Our novel microarray
platform builds upon previously described single base extension
methods employed for SNP detection [15,16]. By using labeled
dideoxynucleotides in our primer extension and replicate arrays,
we were able to identify mutations over a 2643 nucleotide region
without a priori knowledge of specific polymorphisms. Our analyses
of a poliovirus population evolving under the pressure of a
mutagenic drug demonstrate the sensitivity of the platform for
minority genotypes in the background of a complex population. In
this biologically relevant application, we found that the array
correctly identified mutations characteristic of ribavirin’s mode of
action and detected drug resistant variants at an early stage.
A system for accurate measurement of low frequency
polymorphisms
We devoted considerable effort to optimizing each step of the
MDAP protocol. As is the case for many microarray platforms, we
found that proper oligonucleotide design is critical. While 70-mers
provided the best signal to noise ratio, our data suggest that shorter
oligonucleotides could provide adequate performance at a lower
cost. Investigators interested in adapting our platform to other
systems should also use appropriate algorithms to identify
candidate oligonucleotides that can dimerize or adopt secondary
structures. Surprisingly, we found that 39 to 59 oligonucleotide
synthesis resulted in aberrant extension of incomplete oligonucle-
otides and a significant amount of noise. We therefore caution
others to work with their suppliers to identify the appropriate
oligonucleotide synthesis method for this platform. Optimization
of hybridization and extension times yielded smaller but significant
improvements in MDAP performance. Together, these changes
resulted in a signal to noise ratio of 100–250, which translates to a
per SNP detection threshold of between 0.4% and 1%. Our ability
to identify specific point mutants within a complex population
validated the assay’s ability to reproducibly detect polymorphisms
present at less than 1%.
At the lower limit of detection, we found that the sequence
context of a given SNP could have a significant effect on our
sensitivity and specificity. For example, our platform was less
sensitive for minority variants in which two mutations are
separated by less than six bases, and we were unable to detect
variants with neighboring mutations (Figure S9 and data not
shown). While we cannot say how often this would occur in a given
experimental setting, pilot experiments with clinical isolates of
poliovirus indicated that certain naturally occurring variants
would escape detection. The impact of context could potentially
be mitigated by the inclusion of additional oligonucleotides that
would specifically interrogate known minority variants. This
process would, of course, require a priori knowledge of the relevant
mutations, and would be difficult to apply to clinical samples.
Figure 5. Measuring the frequency of the ribavirin resistance mutation. The frequency of a G-to-A mutation at position 6176 of the
poliovirus genome, which is known to confer resistance to ribavirin, is shown on a log scale. Passages 1 and 2 (Blue and Red) are shown for each
concentration of ribavirin (0, 100, 400, 1000 mM).
doi:10.1371/journal.pone.0007453.g005
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We examined the ability of the MDAP platform to measure
changes in the capsid gene of poliovirus, a model RNA virus. The
poliovirus RNA-dependent RNA polymerase exhibits low fidelity
with measured mutation rates of 10
24 to 10
25 mutations per
nucleotide per replication cycle. This high mutation rate is
characteristic of RNA viruses and leads to extraordinary genetic
diversity in RNA virus populations. These populations are termed
‘‘quasispecies,’’ and a growing body of evidence suggests that the
spectrum of mutants within the population determines its
phenotype [19]. Accordingly, population-level responses to
selective pressures, such as drug treatment, are complex. This
system, therefore, offered a unique test of the MDAP platform. In
ribavirin treated populations, we observed an overrepresentation
of G-to-A and C-to-T mutations, consistent with the drug’s known
mode of action [25]. In early passages, many of these
polymorphisms were present at low frequency and would escape
detection by conventional methods. Cluster-based analysis of the
array data allowed us to infer evolutionary dynamics from base-
specific mutation frequencies within the population. Most of the
mutations were synonymous, suggesting that the vast majority of
coding changes result in inviable genomes. Our poliovirus
experiments also allowed us to characterize the emergence of
antiviral drug resistance. We were able detect drug resistant
variants at early passages, well before they dominate the
population.
We developed the MDAP platform as a cost-effective method
for studying the genetic diversity of viral populations. This
diversity is characteristic of RNA viruses, andthe degreetowhich
minority variants influence the adaptability and phenotype of the
population has remained a much debated, but largely unan-
swered, question. While we have achieved our primary goal of
identifying SNPs present at a 0.3–1% frequency, the present
MDAP platform has several limitations. If rare variants in a
population are present at levels below 0.3%, they will likely
escape detection, yet this may include variants that could affect
population dynamics. This problem is not unique to our system,
however, as current deep sequencing technologies have a similar
detection threshold, depending on platform and depth. Our SNP
detection array provides little information on linkage among
mutations or overall haplotype, which is also a problem common
to many resequencing platforms that rely on relatively short
reads. Finally, we have found that highly divergent variants will
escape detection because of inefficient extension from the
consensus oligonucleotides on the array. While this was not a
problem in our experiments, it may be difficult to apply the
MDAP platform to analyze highly variable genomic regions of
complex populations. Given these limitations, the ‘‘sweet spot’’
for MDAP analysis is for populations of sequences derived from a
single consensus and that harbor variants at a frequency of at
least 0.3%.
Comparison to other microarray-based resequencing
platforms
There has been an explosion in high-throughput genotyping
technologies over the last decade. The earliest platforms were built
on standard microarray technology and relied on high-density
arrays with four degenerate probes for each interrogated position
in a given gene [13,14,31,32]. Differential hybridization among
these probes was then used to determine the base at each position.
While advances in photolithography and solid phase oligonucle-
otide synthesis technologies improved the amount of sequence that
could be analyzed with such arrays, this strategy was plagued by
relatively high background and low specificity, as it was highly
sensitive to sequence context. More recent strategies, which rely on
single base extension, require fewer array oligonucleotides per
position, increasing the number of SNPs that can be detected on a
single microarray [15,16]. Although the SBE approach offers
improved scale, performance was optimized mainly to discrimi-
nate between homozygosity and heterozygosity for the purpose of
high throughput genotyping. While the MDAP platform is similar
in design to SBE assays, its improved sensitivity and specificity
allow for accurate quantitation of low frequency polymorphisms
within a mixed population. Like other SBE platforms, it is
hampered by many of the same limitations - difficulties with long
repeats, reduced sensitivity for neighboring mutations, and
reliance on a known reference sequence relatively similar to the
genome to be assayed. Because MDAP, as designed, relies on
spotted microarrays, its resequencing capacity is also lower than
that of commercial SBE platforms, which use higher density,
synthesized arrays or beads to achieve greater throughput. The
choice of platform, therefore, depends on the type of information
required for a given study.
MDAP is extensible to a broad range of biological
applications
Although the MDAP array described here was designed to
assay only the viral capsid sequence of poliovirus,i tc a nb ee a s i l y
extended to monitor the entire genome. Standard spotted
microarrays may contain up to 50,000 features; thus, this
platform provides enough features to assay the entire genome
of many RNA viruses with three-fold or more redundancy.
M o r e o v e r ,t h i sp l a t f o r mi se a s i l ya d a p t e dt oa s s a yaw i d er a n g eo f
populations. The number of microarray-based assays has risen
rapidly in the past few years, resulting in decreased cost and
increased access for researchers to microarray-related resources.
As a result, most research institutions are equipped with the basic
microarray functionality required for the assay described here.
We have also improved access to this technology by developing a
data analysis software package that is freely available to the
scientific community.
The cost of oligonucleotide synthesis is the main barrier to
widespread use of the MDAP platform. This initial cost varies
linearly with the length of the target sequence, and is currently
estimated at $52,087 USD for a complete set of oligonucleotides
designed against a typical picornavirus genome (7,441 nucleotides,
Table S2). For comparison, current startup costs for the ultra high
throughput sequencing (UHTS) approach to complex population
resequencing would be approximately $500,000, not including
yearly maintenance fees (Genome Analyzer, Illumina, Inc). After
the initial startup costs, the recurring cost of the MDAP array is
comparable to that of a typical UHTS platform (Table S2). For
smaller genome sizes (around 14 kb), the two assays are similarly
cost-effective. For larger genomes UHTS based analysis becomes
two or three times as expensive as the microarray, up to the
microarray limit of 50,000 features. With similar per sample costs
and significantly lower initial cost, the microarray platform
proposed here will likely be preferable to UHTS for many
resequencing applications. Both techniques generate mutation
frequencies for each position assayed, and both share limitations
with respect to detection of co-occurring mutations. One
advantage of this platform over UHTS is a significantly lower
cost of failure. A single run of the Genome Analyzer costs around
$4,400, and common failure modes affect either a single lane
($550), or the entire run. Most failure modes of the array described
Single Base Extension by Array
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($100).
In conclusion, we have designed, implemented and demon-
strated a single base extension microarray platform optimized
specifically for use in genotyping complex nucleic acid popula-
tions. Presently, it is one of the more cost effective methods for
such studies, although the ongoing revolution in UHTS may
change this equation in the future [12]. The MDAP array can be
applied to any organism and condition from which a represen-
tative sample of single stranded DNA can be extracted. Because it
can assay tens of thousands of genomic positions simultaneously,
our platform is well suited to answer biological questions requiring
accurate and sensitive detection of single nucleotide mutational
frequencies at a population level.
Materials and Methods
Oligonucleotide design
Oligonucleotides were designed to hybridize to the sense strand
of the capsid region of the poliovirus type 1 (Mahoney) genome.
One oligonucleotide was designed against each 70 bp region of the
capsid, with adjacent oligonucleotides overlapping by 69 nucleo-
tides. A single additional oligonucleotide was designed to hybridize
to the 70 nucleotides 59 of the known ribavirin resistance mutation
(position 6176) [19,30]. Oligonucleotide secondary structure and
dimerization was predicted using MFold v3.1[24], and predicted
base-pairing of 4 or more nucleotides at the 39 terminus of the
oligonucleotide was disrupted by mutating the position predicted
to pair with the 39 most base of the oligonucleotide to its
complement.
Microarray fabrication
The 70-bp oligonucleotides were synthesized (Invitrogen,
Carlsbad, CA), resuspended in 3 x SSC to a final concentration
of 20 mM and spotted onto epoxysilane-coated microscopic slides
(Schott, Louisville, KY). All oligonucleotide sequences are
available at http://derisilab.ucsf.edu/data/MDAP/.
Cells and viruses
HeLa S3 cells (ATCC, CCL-2.2) were propagated in DMEM/
F-12 media (Invitrogen, Carlsbad, CA) supplemented with 10%
fetal bovine serum (SIGMA, St. Louis, MO). Wild-type poliovirus
type 1 Mahoney was generated by electroporation of HeLa S3
cells with in vitro transcribed viral genomes that were derived from
cloned infectious cDNA using T7 RNA polymerase. For virus
passage approximately 10
6 cells were plated in each well of a six-
well plate 12 h prior to infection. One hour prior to infection, cells
were pretreated with ribavirin (SIGMA, St. Louis, MO) or left
untreated. Mutagenesis experiments were done at a multiplicity of
infection (MOI) of 0.1 at 37uC. Cells and tissue culture
supernatants were harvested at complete cytopathic effect (CPE)
and subjected to three cycles of freezing and thawing. Virus
suspensions were clarified by centrifugation and stored at 280uC
until further use.
Template generation
Total RNA was isolated directly from virus suspensions by
TRIzol (Invitrogen, Carlsbad, CA) extraction. Briefly, 500 ml virus
suspension were thoroughly mixed with 500 ml TRIzol and, after
addition of 100 ml chloroform, spun at 12,000 g for 15 min at
4uC. The aqueous phase was extracted with chloroform and the
RNA was precipitated with 2-propanol in the presence of 20 mg
glycogen (Fermentas, Glen Burnie, MD). Pellets were air dried and
resuspended in nuclease-free water.
For first strand cDNA synthesis, 20 ng of total RNA were mixed
with 2 pmol each of primers V3-Oligonucleotide(dT)21 as well as
M.3666REV (59-TGGTACCTAGCTG-39), M.3699REV (59-GA-
TGCGAATCCATG-39), M.3726REV (59-CTGAGTATGCCAC-
C-39), M.3764REV (59-CACCAGCAGTAATG-39), M.3783REV
(59-AATGCAACCAACC-39) and M3840REV (59-GTGATGCCT-
TGTTC-39), which bind to the poliovirus RNA immediately down-
stream of P1.The mixture washeated to 65uCf o ron em i n ut ea n dt h en
chilled on ice for one minute. Reverse transcription was started by
adding MonsterScript 2x cDNA premix (containing buffer, dNTPs
and betaine) and 12.5 U RNaseH-deficient MonsterScript reverse
transcriptase with RNase inhibitor (EPICENTER, Madison, WI). The
total reaction volume was 5 ml. Reverse transcription was carried out
for 5 min at 37uC, 5 min at 42uCa n d1ha t6 0 uC followed by heat
inactivation of the enzyme.
Sequences corresponding to the poliovirus capsid and RNA-
dependent RNA polymerase were amplified between primer pairs
M.501FOR and M.3634REV\T7\ (59-GATTGGCCTGTCG-
TAA CGC-39;5 9-TAATACGACTCACTATAGGGCATGTA-
CTGGAACGTTGGG-39) and M.5781FOR and M.6811REV\
T7\ (59-GTGCTGTGACTGAACAGGGG-39;5 9-TAATACGAC
TCACTATAGGGGTACAGGTGGTGTCAGTGG-39), respective-
ly. Amplification reactions consisted of up to 2.5% first-strand cDNA, 1
x Herculase buffer, 200 mMo fe a c hd N T P ,2 0 0n Mo fe a c hp r i m e r
and 0.05 U/ml Herculase Hotstart DNA polymerase (Stratagene, La
Jolla, CA). Thermal cycling was carried out for 30 cycles of 30 seconds
at 95uC, 30 seconds at 60uC and 1 minute per kb of amplification
p r o d u c ta t7 2 uC.
PCR products carrying the T7 RNA polymerase promoter were
used without further purification to generate complementary RNA
(cRNA). In vitro transcription reactions consisted of up to 10%
PCR product, 1 x in vitro transcription buffer (80 mM HEPES-
KOH pH 7.5, 24 mM MgCl2, 2 mM spermidine, 40 mM
dithiothreitol), 4 mM of each NTP, 0.4 U/ml RNaseOUT
recombinant ribonuclease inhibitor (Invitrogen, Carlsbad, CA)
and T7 RNA polymerase (prepared in house). After incubation at
37uC for 4 hours, template DNA was degraded by adding 0.2 U/ml
RNase-free DNase I (Roche, Indianapolis, IN) with continued
incubation at 37uC for 20 minutes. The cRNA was diluted 1:6 with
nuclease-free water and ammonium acetate to a final concentration
of 0.5 M ammonium acetate and extracted with phenol:chlorofor-
m:isoamyl alcohol (25:24:1; Invitrogen, Carlsbad, CA), followed by
a chloroform extraction. The cRNA containing aqueous phase was
precipitated in the presence of an equal volume of 2-propanol.
Pellets were air dried and resuspended in nuclease-free water.
Single-stranded microarray template DNA was generated by
reverse transcription of the cRNA in the presence of random
hexamers. To this end, 6 mg cRNA were mixed with 300 mg
random hexamers in a total volume of 30 ml, heated to 70uC for
five minutes and chilled on ice for one minute. Reverse
transcription was started by adding 30 ml reverse transcription
premix, containing 2x reverse transcriptase buffer (100 mM Tris-
HCl pH 8.3, 150 mM KCl, 12 mM MgCl2), 1 mM of each
dNTP, 10 mM dithiothreitol, 1.33 U/ml RNaseOUT recombinant
ribonuclease inhibitor (Invitrogen, Carlsbad, CA) and reverse
transcriptase (prepared in house). The mixture was incubated for
10 minutes at 20uC and subsequently for three hours at 42uC.
After heat inactivation of the enzyme, the input cRNA was
hydrolyzed for 20 minutes at 65uC in the presence of 0.2 mM
NaOH and 20 mM EDTA. After adding 1 Vol. 1 M HEPES-
KOH pH 7.5 and 0.2 Vol. 3 M sodium acetate pH 5.2, single-
stranded microarray template DNA was purified over a QIAquick
column (QIAGEN, Valencia, CA) following the manufacturer’s
instructions.
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Two 0.2 mm strips of microtiter plate sealing film were applied
along the long edge of the glass slides leaving narrow spaces
between the strips and the microarrays. Prior to hybridization of
single-stranded template DNA to the microarrays, unreacted
epoxy groups were blocked by incubating the slides for 20 minutes
at 50uC in 0.1 M Tris-HCl pH 9.0 containing 50 mM ethanol-
amine and 0.1% SDS. The volume of blocking solution should be
at least 20 ml per slide. After blocking, slides were rinsed in six
changes of deionized water and dried by centrifugation.
Four identical microarrays (two per slide) for every viral
population to be sequenced were placed into a hybridization
chamber (Die-Tech, San Jose, CA). Using the two film strips as
support, glass cover slips were positioned above each microarray.
For each array, 30 ml hybridization solution containing 1 mg single
stranded template DNA in 3 x SSC, 25 mM HEPES-KOH
pH 7.5 and 0.25% SDS were heated to 95uC for three minutes
and then allowed to cool to ambient temperature. The
hybridization solution was injected between the microarray slide
and the cover slip and hybridization reactions were incubated at
65uC for 10 minutes. Slides were washed for 10 minutes at 60uCi n
0.5 x SSC and 0.025% SDS, followed by 10 minutes at ambient
temperature in 0.05 x SSC. The arrays were dried by brief
centrifugation, placed back into the hybridization chamber and
covered with new cover slips.
Each one of four microarrays was incubated with 30 ml of one of
four different extension solutions (A, C, G or U) containing 1 x
extension buffer (26 mM Tris-HCL pH 9.5, 6.5 mM MgCl2),
3.2 mM array-specific Cyanine-labeled dideoxynucleotides
(ddNTP) and 6.6 U/ml thermosequenase DNA polymerase (USB
Corporation). For example, extension solution A contained
400 nM Cyanine-3 ddATP, 400 nM Cyanine-5 ddATP,
800 nM Cyanine-3 ddCTP, 800 nM Cyanine-3 ddGTP and
800 nM Cyanine-3 ddUTP (Perkin Elmer, Waltham, MA).
Extension solutions C, G and U had an analogous composition.
Extension solutions were injected between the microarray slide
and the cover slip and single base extension was allowed to
proceed for ten minutes at 65uC. After a stringent wash for 10
minutes at 95uC in 1% SDS, microarrays were dried by
centrifugation and scanned at 5 mm resolution on a GenePix
4000B scanner (Molecular Devices, Sunnyvale, CA) and analyzed
using software developed in-house (see below).
Data Analysis
Analysis of microarray data was performed using the open
source software package MDAP, developed by the authors for
microarray based mutation distribution analysis. (http://derisilab.
ucsf.edu/software/MDAP/). P-values within the text were calcu-
lated using the Student’s T-test, and both z-scores and t-tests were
computed using the SciPy [33] software package.
Supporting Information
Figure S1 Oligonucleotides of length 20 to 70 nucleotides were
hybridized and extended with wild-type poliovirus template.
Measurements were made for three genomic positions on four
replicate arrays. The mean extension signal 6 standard deviation
(y-axis) is plotted against oligonucleotide length (x-axis).
Found at: doi:10.1371/journal.pone.0007453.s001 (0.45 MB TIF)
Figure S2 (A) Oligonucleotides with a sequence at the 39-end
(red) that is complementary to a sequence elsewhere in the
oligonucleotide (blue) can form dimers or hairpins as shown. Both
structures can prime themselves in the absence of hybridized
sample DNA, potentially leading to inappropriate extension
(green). (B) A mutation at the position indicated in yellow disrupts
extension for both the hairpin and dimmer. (C) Three examples of
positions (genomic coordinates 2672, 2765, and 3284) in which
oligonucleotide mutation prevented dimer-mediated extension.
The background color represents the nucleotide expected to
extend at the given position, and four foreground bars (some too
short to be visible) represent the observed base-specific signals. For
each position, unmodified oligonucleotide signal is shown on the
left, and signal from the oligonucleotide modified to disrupt
secondary structure is shown on the right.
Found at: doi:10.1371/journal.pone.0007453.s002 (0.89 MB TIF)
Figure S3 (A) Extension from an oligonucleotide with an intact
39 end, representing the signal observed for ‘correct’ incorpora-
tion. (B) Extension observed when the oligonucleotide is missing its
39-most nucleotide. This generates a pattern where the mutation
with the highest noise from a given oligonucleotide matches the
expected signal from the 59 neighboring oligonucleotide
Found at: doi:10.1371/journal.pone.0007453.s003 (0.16 MB TIF)
Figure S4 Template from in vitro transcribed RNA was
hybridized and extended on the surface of the array to determine
oligonucleotide-specific noise levels. Any signal observed on
oligonucleotides designed to assay mutations is assumed to derive
from oligonucleotide-specific noise. Noise distributions are shown
for oligonucleotides synthesized at Invitrogen’s Hayward, CA
facility in blue and the Frederick, MD facility in red. X-axis values
are computed as described in equations 1–3 from the text, and y-
axis values represent oligonucleotide counts.
Found at: doi:10.1371/journal.pone.0007453.s004 (0.58 MB TIF)
Figure S5 Nucleotide-specific extension intensities are shown for
(A) double stranded and (B) single stranded DNA samples
prepared from in vitro transcribed poliovirus RNA. Y-axis values
represent fluorescent signal intensities from Cy5 labeled ddNTPs,
with a different labeled nucleotide added to each of four arrays as
described in Figure 1. Only oligonucleotides templated with the
expected wild-type nucleotide (denoted by color of data point)
should be extended with Cy5 labeled ddNTPs in this homoge-
neous population. X-axis values represent fluorescence from
extended Cy3 labeled ddNTPs, added as a mixture of all four
nucleotides to each array. Since all oligonucleotides should extend
Cy3 labeled ddNTPs, this signal is used as an indication of the
total amount of extension per oligonucleotide. The signal-to-noise
ratios are roughly equivalent to the distance between the two
clusters of oligonucleotides observed in each graph.
Found at: doi:10.1371/journal.pone.0007453.s005 (0.80 MB TIF)
Figure S6 Noise distribution graphs are shown for hybridization
times of 12 hours, 5 hours, 4 hours, 2 hours, and 30 minutes. Line
height represents the number of oligonucleotides showing the
noise level specified on the x-axis. All data were generated from
homogeneous in vitro transcribed poliovirus RNA samples.
Found at: doi:10.1371/journal.pone.0007453.s006 (0.78 MB TIF)
Figure S7 To determine the effect of extension time on the
signal-to-noise ratio of the array, single ‘‘A’’ arrays were hybrid-
ized with in vitro transcribed poliovirus RNA and extended
for (A) 1 hour, (B) 20 minutes, and (C) 5 minutes. Each data point
denotes the Cy5 (y axis), Cy3 (x axis), and expected extension base
(color) of a single oligonucleotide. Signal-to-noise ratio of the full
array is approximated here by the median distance between the
‘‘signal’’ cluster of oligonucleotides (red data points high on
the y axis) and the ‘‘noise’’ cluster (green, blue, yellow data
points).
Found at: doi:10.1371/journal.pone.0007453.s007 (0.88 MB TIF)
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otides is shown. DNA from in vitro transcribed RNA was
hybridized and extended on the array. Any signal corresponding
to a base call different from the wild type poliovirus sequence was
considered to be noise.
Found at: doi:10.1371/journal.pone.0007453.s008 (0.46 MB TIF)
Figure S9 Normal single base extension from templated
oligonucleotides (A) is affected by mismatches between the
oligonucleotide and template (B). Mismatches near the 39 end
result in decreased signal and extension fidelity (C).
Found at: doi:10.1371/journal.pone.0007453.s009 (0.08 MB TIF)
Figure S10 The difference between the average z-score for
nonsynonymous mutations and synonymous mutations is shown
on the y axis for each codon in the poliovirus capsid (x-axis).
Values greater than zero indicate higher average significance of
nonsynonymous mutations, and suggest positive selection. Values
below zero indicate higher average significance of synonymous
mutations, which suggests neutral mutation. No data was obtained
for the indicated region of the capsid due to manufacturing defects
in the oligonucleotides designed to assay that region.
Found at: doi:10.1371/journal.pone.0007453.s010 (0.82 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0007453.s011 (0.03 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0007453.s012 (0.04 MB
DOC)
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